Mitra’s research interest is in personalized medicine, a medical model that uses genomic, physiological, and environmental factors associated with a disease to separate people into different groups who respond differently to specific prevention or therapies. She is particularly interested in identifying biomarkers for early detection and therapies for prevention of complications in patients with chronic diseases such as type 1 diabetes. Mitra earned an MS in System Biology from Gothenburg University (Sweden) and an MS in Epidemiology from the University of California, Irvine (UCI). After graduating from UCI, she worked as a researcher with the Heart Disease Prevention Program and the Harold Simmons Kidney Research Center at UCI, Department of Medicine. Currently, Mitra is a PhD student in epidemiology, working under the supervision of Dr. Tina Costacou.

Select presentations

• Mosslemi M, Hanna RM, Rhee CM, Kalantar-Zadeh K, Streja E. Comparison of chronic kidney disease risk factors between normoalbuminuric and albuminuric patients with diagnosed diabetes and reduced kidney function. [Poster Presentation] American Diabetes Association 80th Scientific Sessions. Online, June 12-16, 2020. 

• Mosslemi M, Wong ND. “Oral Glucose Tolerance Test Detects Diabetes at Early Stages.” [Poster Presentation] American Heart Association EPI|LIFESTYLE 2020 Scientific Sessions. Phoenix, AZ, USA; March 3-6, 2020. 

• Mosslemi M, Park HL, McLaren CE, Wong ND. “Treatment-based approach for Diabetes Type Identification in the National Health and Nutrition Examination Survey.” [Poster Presentation] Society for Epidemiologic Research 52nd Annual Meeting. Minneapolis, MN, USA; June 18-21, 2019. 

• Mosslemi M, Park HL, McLaren CE, Wong ND. “Comparison of cardiovascular risk factors between type 1 and type 2 diabetes in United States adults.” [Poster Presentation] American Diabetes Association 79th Scientific Sessions. San Francisco, CA, USA; June 7-11, 2019. 

Select publications 

• Mosslemi M, Wong ND. Importance of applying treatment data to ascertain type 1 diabetes cases in health registries. BMJ Open Diabetes Research and Care 2021; 9 (1), e002280. doi: 10.1136/bmjdrc-2021-002280 

• Mosslemi M, Park HL., McLaren CE., Wong ND. Treatment-based Algorithm for Identification of Diabetes Type in the National Health and Nutrition Examination Survey. Cardiovascular Endocrinology & Metabolism 2020;9(1):9–16. doi: 10.1097/XCE.0000000000000189 

• Nørgaard CH, Mosslemi M, Lee CJ, Torp-Pedersen C, Wong ND. The Importance and Role of Multiple Risk Factor Control in Type 2 Diabetes. Current Cardiology Reports 2019; 21: 35. doi.org/10.1007/s11886-019-1123-y 

• Hubaux R, Thu KL, Vucic E, Pikor L, Kung S, Martinez V, Mosslemi M, Becker-Santos D, Gazdar AF, Lam S, Lam WL. Microtubule affinity-regulating kinase 2 is associated with DNA damage response and cisplatin resistance in non-small cell lung cancer. International Journal of Cancer 2015;137(9):2072–82. doi: 10.1002/ijc.29577